6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
7m ago	Cushman & Wakefield Arranges $74.1 Million Financing for Bank of Italy Office-to-Residential Conversion in Downtown San Jose
14m ago	EVS Broadcast Equipment : announces CFO transition following five years of record growth
16m ago	Duke Energy : Florida completes solar energy site in Sumter County, estimates $250 million in customer savings over its service lifetime
18m ago	Kraft Heinz Announces Pricing Terms and the Accepted Tender Amounts for the Cash Tender Offer for Up To $1.1 Billion Aggregate Purchase Price of Certain of Its Outstanding Notes
18m ago	L.B. Foster Company Announces the Appointment of Executive Officers

About

1.50USD-0.11 -6.83%

Closed • Updated at 18:54 GMT+00:00

Market Cap$178.28M

Volume924.4K

Beta-0.73

RSI56.24

Health TechnologyPharmaceuticals: Major

Tiziana Life Sciences Ltd — investor relations, events, news, and company updates on 6ix.

Latest News

Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress

Community Chat

Ask AI